Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y P Samarasinghe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Heart (British Cardiac Society)|December 17, 2003
Calcium channel blocker induced gum hypertrophy: no class distinctionY P Samarasinghe, A Cox, M D Feher
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2001
Avascular necrosis not Charcot'sY P Samarasinghe, S L Brunton, M D Feher
Clinical Endocrinology|January 7, 2010
Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesityL Yang, Y P Samarasinghe, P Kane, et al.
International Journal of Clinical Practice|February 3, 2006
Erectile dysfunction and statin treatment in high cardiovascular risk patientsH Solomon, Y P Samarasinghe, M D Feher, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Heart (British Cardiac Society)|December 17, 2003
Calcium channel blocker induced gum hypertrophy: no class distinctionY P Samarasinghe, A Cox, M D Feher
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2001
Avascular necrosis not Charcot'sY P Samarasinghe, S L Brunton, M D Feher
Clinical Endocrinology|January 7, 2010
Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesityL Yang, Y P Samarasinghe, P Kane, et al.
International Journal of Clinical Practice|February 3, 2006
Erectile dysfunction and statin treatment in high cardiovascular risk patientsH Solomon, Y P Samarasinghe, M D Feher, et al.
Pageof 1